## Abstract Genetic engineering with osteogenic factors is a promising approach for cell‐based therapeutics and orthopedic regeneration. However, the relative efficacy of different strategies for inducing osteoblastic differentiation remains unclear and is further complicated by varied delivery veh
BMP-2 promotes differentiation of osteoblasts and chondroblasts in Runx2-deficient cell lines
✍ Scribed by Tingjiao Liu; Yuhao Gao; Kei Sakamoto; Tokutaro Minamizato; Keizo Furukawa; Tomoo Tsukazaki; Yasuaki Shibata; Kazuhisa Bessho; Toshihisa Komori; Akira Yamaguchi
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 259 KB
- Volume
- 211
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
To investigate the molecular mechanism underlying the differentiation of osteoblasts and chondroblasts, we established a clonal cell lines, RD‐C6, from Runx2‐deficient mouse embryos. RD‐C6 cells expressed almost undetectable levels of phenotypes related to osteoblast and chondroblast differentiation at basal culture condition, whereas treatment with recombinant human bone morphogenetic protein‐2 (rhBMP‐2) or transduction of BMP‐2 by adenovirus effectively induced this cell line to express mRNA related to the differentiation of osteoblasts and chondroblasts including alkaline phosphatase, osteocalcin, and osterix. Transduction of Runx2 also induced the expression of these mRNA in RD‐C6 cells. BMP‐2 transduction increased expression levels of mRNA for Msx2 and Dlx5, but Runx2 transduction induced no significant increases in expression levels of these mRNA. Microarray analysis using RD‐C6 cells with or without rhBMP‐2 treatment demonstrated that BMP‐2 upregulated 66 genes including 13 transcription‐related molecules such as Id1, Id2, Id4, Hey1, Smad6, Smad7, and Msx2. To confirm bone and cartilage formation ability of RD‐C6 cells, we transplanted RD‐C6 cells into the peritoneal cavity of athymic mice using diffusion chambers with rhBMP‐2. RD‐C6 cells generated unmineralized cartilage but not bone. These results indicate that BMP‐2 induces Runx2‐deficient cells to express markers related to osteoblast and chondroblast differentiation using a Runx2‐independent pathway, but it failed to induce these cells to differentiate into bone‐forming osteoblasts and mature chondrocytes. J. Cell. Physiol. 211: 728–735, 2007. © 2007 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract The Runx2/Cbfa1 transcription factor is a scaffolding protein that promotes osteoblast differentiation; however, the specific Runx2‐functional domains required for induction of the osteogenic lineage remain to be identified. We approached this question using a TERT‐immortalized cell lin
## Abstract Cbl‐b is a member of Cbl family of E3 ubiquitin (Ub) ligase. Besides the important role in ubiquitination process, other members of Cbl family have been suggested to show non‐ubiquitination‐related function in regulation of osteoblastic differentiation. However, the role of Cbl‐b in reg
## Abstract Runx2 is an osteoblast master transcription factor and a target for bone morphogenetic protein (BMP) signaling, but our knowledge of events downstream of Runx2 is limited. In this study, we used ChIP Display to discover seven novel genomic regions occupied by Runx2 in living MC3T3‐E1 os
## Abstract The Runx2 factor is an essential component of the regulatory mechanisms that control transcription during skeletogenesis. Runx2/p57 expression in osteoblastic cells is controlled by the P1 promoter, which is recognized by key regulators of osteoblast differentiation including homeodomai
## Abstract In the current study, treatment of the rat osteogenic cell line ROB‐C26 cells with fibroblast growth factor 8 (FGF8) stimulated alkaline phosphatase (ALP) activity, and also induced the expression of the Runx2 transcription factor, and increased the activity of a luciferase reporter gen